AB 1460 (Rogers, D-Santa Rosa) Details
Passed the Assembly on May 19. July 2 hearing in the Senate Health Committee postponed.
AB 1460 would prohibit drug manufacturers from engaging in discriminatory practices that prevent or interfere with a qualifying nonhospital 340B community clinic’s ability to purchase or deliver 340B discounted drugs through contract pharmacies. This bill would also allow prescription drug manufacturers to request deidentified claims data from 340B-covered entities once a year to investigate duplicate discounts or validate claim eligibility.
Mark Farouk
Adam Dorsey